Diagnamed Holdings Corp. (DMED.CN)
| Previous Close | 0.0350 |
| Open | 0.0350 |
| Bid | 0.0350 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 0.0350 - 0.0350 |
| 52 Week Range | 0.0200 - 0.1000 |
| Volume | |
| Avg. Volume | 116,224 |
| Market Cap | 2.802M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireDiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, today announced a clinical validation milestone of the BRAIN AGE® Brain Health AI Platform (“BRAIN AGE®”), a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score, with a first-of-a-kind peer-reviewed paper in Frontiers in Neuroergonomics, ti
- GlobeNewswire
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
Clinics can apply at BrainAge.ca TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, today announced that BRAIN AGE® Brain Health AI, a world-first consumer brain health and wellness AI solution that estimates brain age and provides a brain health score, is available to Canadian-based clinics focusing on health and wellness, sports and physical therapy, me
GlobeNewswireDiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, today announced it has added Drexel University as a new test launch site of CERVAI™, a world-first consumer brain health and wellness AI solution. The Company continues to expand its commercial initiatives in the U.S. and Canada for its CERVAI™ Brain Health AI Platform, which includes the BRAIN AGE® estimation solut
